Sign in
Taking people in United StatesNo phase

QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing

Key facts

Who runs it
Anna Evans Phillips
Where
Baltimore and Pittsburgh, United StatesSee the 2 sites
Trial code
Status
Recruiting
People taking part
500 people, planned
Started
24 Oct 2017
Expected to end
30 Jun 2031
Type of study
Interventional, 4 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Quantitative Sensory Test 1
  • Quantitative Sensory Test 2
  • Quantitative Sensory Test 3
Record updated
11 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Subjects with no pancreatic disease and no abdominal pain, or patients with a diagnosis of functional dyspepsia; Subjects are 18 years or older in age; Subjects must be able to read and understand the study information; Personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study; Subject is willing and able to comply with the scheduled visits, questionnaires, treatment plan, and other study procedures
  • Suspected CPs Inclusion Criteria; Subjects are 18 years or older in age; Subjects with a) Indeterminate CP (Cambridge 1 or 2 on CT scan or MRI/MRCP) who have abdominal pain without prior history of AP, or b) those with acute (AP) or recurrent acute pancreatitis (RAP) who have recovered from their attack(s) of AP, whose imaging studies are either normal or show changes consistent with Cambridge classification of 1 or 2, and they have ongoing abdominal pain. Both diabetic and non-diabetic subjects will be allowed to enter the study; Subjects must be able to read and understand the study information; Subjects must suffer from abdominal pain suspected to be pancreatic origin with an intensity above 3 on the visual analogue scale (VAS, where 0=no pain and 10= intolerable pain), and meet the criteria for chronic pain (pain ≥ 3 days per week for at least 3 months); Personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study; Subjects willing and able to comply with the scheduled visits, questionnaires, and other study procedures
  • Definite Chronic Pancreatitis - Inclusion Criteria; Subjects are 18 years or older in age; Subjects will have a prior confirmed diagnosis of CP on CT scan or MRI/MRCP according to Cambridge Classification (grade 3 or 4). Both diabetic and non-diabetic subjects will be allowed to enter the study; Subjects must be able to read and understand the study information; Personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study; Subjects willing and able to comply with the scheduled visits, questionnaires, and other study procedures
  • Sphincter of Oddi Dysfunction (SOD) Type 1 or Type 2 Inclusion Criteria; Subjects are 18 years or older in age; Subjects have prior diagnosis of Type 1 or Type 2 Sphincter of Oddi Dysfunction (subjects with biliary pain accompanied by biochemical features of transient biliary tract obstruction including elevated transaminases, alkaline phosphatase, or conjugated bilirubin; may also be accompanied by biliary or pancreatic ductal dilation on imaging); Subjects must be able to read and understand the study information; Personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study; Subjects willing and able to comply with the scheduled visits, questionnaires, and other study procedures

Who cannot take part

  • Subjects with no pancreatic disease and no abdominal pain, or patients with a diagnosis of functional dyspepsia; Subjects with evidence or history of medical or surgical disease of importance for this study as judged by investigator; Subjects suffering from painful conditions that make them unable to distinguish the pain associated with CP from chronic pain of other origins; Subjects with known pregnancy at the time of enrolment; Subjects who have previously undergone surgical intervention on their pancreas
  • Suspected CPs Exclusion Criteria; Subjects with evidence or history of medical or surgical disease of importance for this study as judged by investigator; Subjects suffering from painful conditions other than pancreatitis or SOD type 1 or 2 that make them unable to distinguish the pain associated with pancreatitis or SOD from chronic pain of other origins; Subjects with known pregnancy at the time of enrolment; Subjects who have previously undergone surgical intervention on their pancreas
  • Definite Chronic Pancreatitis Exclusion Criteria; Subjects with evidence or history of medical or surgical disease of importance for this study as judged by investigator; Subjects suffering from painful conditions other than pancreatitis or SOD type 1 or 2 that make them unable to distinguish the pain associated with pancreatitis or SOD from chronic pain of other origins; Subjects with known pregnancy at the time of enrolment; Subjects who have previously undergone surgical intervention on their pancreas
  • Sphincter of Oddi Dysfunction (SOD) Type 1 or Type 2 Exclusion Criteria; Subjects with evidence or history of medical or surgical disease of importance for this study as judged by investigator; Subjects suffering from painful conditions other than pancreatitis or SOD that make them unable to distinguish the pain associated with pancreatitis or SOD from chronic pain of other origins; Subjects with known pregnancy at the time of enrolment; Subjects who have previously undergone surgical intervention on their pancreas

Where in United States

  • Johns Hopkins Medical InstitutionsBaltimore, United StatesContact: Mahya Faghih, M.D.Taking people
  • University of Pittsburgh Medical CenterPittsburgh, United StatesContact: Anna Evans-Phillips, MDTaking people

About the trial

What the trial wants to find out

Quantitative Sensory Testing (QST) is a novel investigative technique used in other pain conditions to evaluate patterns of chronic pain, and in this study will be used to elucidate pain patterns in patients with Chronic Pancreatitis (CP). QST uses a specific series of standardized stimulations to map the pain system. QST has the potential to change and improve the treatment paradigm for patients with CP and may eventually be able to predict response to invasive CP therapies.

The 4 groups in the trial

  • Healthy ControlsExisting treatment, for comparison

    Subjects with no pancreatic disease and no abdominal pain. Subjects will undergo the following Interventions: Quantitative Sensory Test 1, Quantitative Sensory Test 2, and Quantitative Sensory Test 3, They will also fill out validated questionnaires.

    Treatment: Quantitative Sensory Test 1, Quantitative Sensory Test 2, and Quantitative Sensory Test 3

  • Suspected CPExisting treatment, for comparison

    Suspected Chronic Pancreatitis patients. Subjects will undergo the following Interventions: Quantitative Sensory Test 1, Quantitative Sensory Test 2, and Quantitative Sensory Test 3, They will also fill out validated questionnaires.

    Treatment: Quantitative Sensory Test 1, Quantitative Sensory Test 2, and Quantitative Sensory Test 3

  • Definite CPExisting treatment, for comparison

    Definite Chronic Pancreatitis patients. Subjects will undergo the following Interventions: Quantitative Sensory Test 1, Quantitative Sensory Test 2, and Quantitative Sensory Test 3, They will also fill out validated questionnaires. A subset of these patients who undergo endotherapy as per clinical recommendation from clinical provider independent of this study will be followed for 6 months after their clinical intervention for repeat Quantitative Sensory Test 1, Quantitative Sensory Test 2, and Quantitative Sensory Test 3 and questionnaires.

    Treatment: Quantitative Sensory Test 1, Quantitative Sensory Test 2, and Quantitative Sensory Test 3

  • Sphincter of Oddi Dysfunction or Functional DyspepsiaExisting treatment, for comparison

    Patients with Sphincter of Oddi Dysfunction Type 1 or Type 2, or who have a prior diagnosis of Functional Dyspepsia. Subjects will undergo the following Interventions: Quantitative Sensory Test 1, Quantitative Sensory Test 2, and Quantitative Sensory Test 3, They will also fill out validated questionnaires.

    Treatment: Quantitative Sensory Test 1, Quantitative Sensory Test 2, and Quantitative Sensory Test 3

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
11 September 2026